Bone healing induced by local delivery of an engineered parathyroid hormone prodrug

Biomaterials

Volumn 30, Issue 9, 2009, Pages 1763-1771

  Arrighi, Isabelle ^a   Mark, Silke ^a   Alvisi, Monica ^a   von Rechenberg, Brigitte ^b   Hubbell, Jeffrey A ^c   Schense, Jason C ^a  

^a Kuros Biosurgery AG   (Switzerland)

^b VETSUISSE FACULTY UNIVERSITY OF ZURICH   (Switzerland)

^c EPFL   (Switzerland)

Author keywords

Bone graft; Bone healing; Fibrin; Osteoblast; Peptide

Indexed keywords

BONE GRAFT; BONE HEALING; FIBRIN; OSTEOBLAST; PEPTIDE;

AMINES; GRAFTING (CHEMICAL); GRAFTS; OSTEOBLASTS; REPAIR;

BONE;

FIBRIN; PARATHYROID HORMONE RECEPTOR; PARATHYROID HORMONE[1-34]; PLASMIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE CONDUCTION; BONE REGENERATION; CELL INVASION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; FRACTURE HEALING; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; SHEEP;

ANIMALS; BIOLOGICAL ASSAY; BONE AND BONES; DRUG DELIVERY SYSTEMS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FIBRIN; HUMANS; PARATHYROID HORMONE; PLASMIN; PRODRUGS; RECEPTORS, PARATHYROID HORMONE; SHEEP; TRANSGLUTAMINASES; WOUND HEALING;

ANIMALIA;

EID: 59149093935     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2008.12.023     Document Type: Article

References (50)

1. Lane J.M., Tomin E., and Bostrom M.P. Biosynthetic bone grafting. Clin Orthop Relat Res 367 (1999) S107-S117
2. Arrington E.D., Smith W.J., Chambers H.G., Bucknell A.L., and Davino N.A. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res 329 (1996) 300-309
3. Younger E.M., and Chapman M.W. Morbidity at bone graft donor sites. J Orthop Trauma 3 (1989) 192-195
4. Dimitriou R., Tsiridis E., and Giannoudis P.V. Current concepts of molecular aspects of bone healing. Injury 36 (2005) 1392-1404
5. Kalfas I.H. Principles of bone healing. Neurosurg Focus 10 (2001) E1
6. Cheung C. The future of bone healing. Clin Podiatr Med Surg 22 (2005) 631-641
7. Branfoot T. Research directions for bone healing. Injury 36 Suppl. 3 (2005) S51-S54
8. Hong S.J., Kim C.S., Han D.K., Cho I.H., Jung U.W., Choi S.H., et al. The effect of a fibrin-fibronectin/beta-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects. Biomaterials 27 (2006) 3810-3816
9. Bonadio J., Smiley E., Patil P., and Goldstein S. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat Med 5 (1999) 753-759
10. Meinel L., Zoidis E., Zapf J., Hassa P., Hottiger M.O., Auer J.A., et al. Localized insulin-like growth factor I delivery to enhance new bone formation. Bone 33 (2003) 660-672
11. Lutolf M.P., Weber F.E., Schmoekel H.G., Schense J.C., Kohler T., Muller R., et al. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat Biotechnol 21 (2003) 513-518
12. Schense J.C., and Hubbell J.A. Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa. Bioconjug Chem 10 (1999) 75-81
13. Pisano J.J., Finlayson J.S., and Peyton M.P. Cross-link in fibrin polymerized by factor 13: epsilon-(gamma-glutamyl)lysine. Science 160 (1968) 892-893
14. Folk J.E. Mechanism of action of guinea pig liver transglutaminase. VI. Order of substrate addition. J Biol Chem 244 (1969) 3707-3713
15. Doolittle R.F., Chen R., and Lau F. Hybrid fibrin: proof of the intermolecular nature of - crosslinking units. Biochem Biophys Res Commun 44 (1971) 94-100
16. McDonagh R.P., McDonagh J., Petersen T.E., Thogersen H.C., Skorstengaard K., Sottrup-Jensen L., et al. Amino acid sequence of the factor XIIIa acceptor site in bovine plasma fibronectin. FEBS Lett 127 (1981) 174-178
17. 2-terminal peptide of alpha 2-plasmin inhibitor to fibrin. FEBS Lett 153 (1983) 369-371
18. Sakiyama-Elbert S.E., Panitch A., and Hubbell J.A. Development of growth factor fusion proteins for cell-triggered drug delivery. FASEB J 15 (2001) 1300-1302
19. Schense J.C., Bloch J., Aebischer P., and Hubbell J.A. Enzymatic incorporation of bioactive peptides into fibrin matrices enhances neurite extension. Nat Biotechnol 18 (2000) 415-419
20. Sakiyama S.E., Schense J.C., and Hubbell J.A. Incorporation of heparin-binding peptides into fibrin gels enhances neurite extension: an example of designer matrices in tissue engineering. FASEB J 13 (1999) 2214-2224
21. Schmoekel H.G., Weber F.E., Schense J.C., Gratz K.W., Schawalder P., and Hubbell J.A. Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell in growth matrices. Biotechnol Bioeng 89 (2005) 253-262
22. Schmoekel H.G., Weber F.E., Hurter K., Schense J.C., Seiler G., Ryrz U., et al. Enhancement of bone healing using non-glycosylated rhBMP-2 released from a fibrin matrix in dogs and cats. J Small Anim Pract 46 (2005) 17-21
23. Schmokel H.G., Weber F.E., Seiler G., von Rechenberg B., Schense J.C., Schawalder P., et al. Treatment of nonunions with nonglycosylated recombinant human bone morphogenetic protein-2 delivered from a fibrin matrix. Vet Surg 33 (2004) 112-118
24. Zisch A.H., Schenk U., Schense J.C., Sakiyama-Elbert S.E., and Hubbell J.A. Covalently conjugated VEGF-fibrin matrices for endothelialization. J Control Release 72 (2001) 101-113
25. Poole K.E., and Reeve J. Parathyroid hormone - a bone anabolic and catabolic agent. Curr Opin Pharmacol 5 (2005) 612-617
26. Carter P.H., and Schipani E. The roles of parathyroid hormone and calcitonin in bone remodeling: prospects for novel therapeutics. Endocr Metab Immune Disord Drug Targets 6 (2006) 59-76
27. Pfeilschifter J., Laukhuf F., Muller-Beckmann B., Blum W.F., Pfister T., and Ziegler R. Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone. J Clin Invest 96 (1995) 767-774
28. Blair H.C., Zaidi M., and Schlesinger P.H. Mechanisms balancing skeletal matrix synthesis and degradation. Biochem J 364 (2002) 329-341
29. Cranney A., Papaioannou A., Zytaruk N., Hanley D., Adachi J., Goltzman D., et al. Parathyroid hormone for the treatment of osteoporosis: a systematic review. Can Med Assoc J 175 (2006) 52-59
30. Whitfield J.F. Osteoporosis-treating parathyroid hormone peptides: What are they? What do they do? How might they do it?. Curr Opin Investig Drugs 7 (2006) 349-359
31. Grey A. Emerging pharmacologic therapies for osteoporosis. Expert Opin Emerg Drugs 12 (2007) 495-508
32. Fang J., Zhu Y.Y., Smiley E., Bonadio J., Rouleau J.P., Goldstein S.A., et al. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci U S A 93 (1996) 5753-5758
33. Ballestar E., Abad C., and Franco L. Core histones are glutaminyl substrates for tissue transglutaminase. J Biol Chem 271 (1996) 18817-18824
34. Ballestar E., and Franco L. Use of the transglutaminase reaction to study the dissociation of histone N-terminal tails from DNA in nucleosome core particles. Biochemistry (Moscow) 36 (1997) 5963-5969
35. Hohl D., Aeschlimann D., and Huber M. In vitro and rapid in situ transglutaminase assays for congenital ichthyoses - a comparative study. J Invest Dermatol 110 (1998) 268-271
36. Haramoto N., Kawane T., and Horiuchi N. Upregulation of PTH receptor mRNA expression by dexamethasone in UMR-106 osteoblast-like cells. Oral Dis 13 (2007) 23-31
37. Fluhmann B., Zimmermann U., Muff R., Bilbe G., Fischer J.A., and Born W. Parathyroid hormone responses of cyclic AMP-, serum- and phorbol ester-responsive reporter genes in osteoblast-like UMR-106 cells. Mol Cell Endocrinol 139 (1998) 89-98
38. Kawane T., Mimura J., Fujii-Kuriyama Y., and Horiuchi N. Parathyroid hormone (PTH) suppresses rat PTH/PTH-related protein receptor gene promoter. Biochem Biophys Res Commun 287 (2001) 313-322
39. Nuss K.M.R., Auer J.A., Boos A., and von Rechenberg B. An animal model in sheep for biocompatibility testing of biomaterials in cancellous bones. BMC Musculoskelet Disord 7 (2006) 67
40. Theiss F., Apelt D., Brand B., Kutter A., Zlinszky K., Bohner M., et al. Biocompatibility and resorption of a brushite calcium phosphate cement. Biomaterials 26 (2005) 4383-4394
41. Apelt D., Theiss F., El-Warrak A.O., Zlinszky K., Bettschart-Wolfisberger R., Bohner M., et al. In vivo behavior of three different injectable hydraulic calcium phosphate cements. Biomaterials 25 (2004) 1439-1451
42. von Doernberg M.C., von Rechenberg B., Bohner M., Grünenfelder S., van Lenthe G.H., Müller R., et al. In vivo behavior of calcium phosphate scaffolds with four different pore sizes. Biomaterials 27 (2006) 5186-5198
43. Kawane T., Mimura J., Yanagawa T., Fujii-Kuriyama Y., and Horiuchi N. Parathyroid hormone (PTH) down-regulates PTH/PTH-related protein receptor gene expression in UMR-106 osteoblast-like cells via a 3′,5′-cyclic adenosine monophosphate-dependent, protein kinase A-independent pathway. J Endocrinol 178 (2003) 247-256
44. Fujimori A., Cheng S.L., Avioli L.V., and Civitelli R. Structure-function relationship of parathyroid hormone: activation of phospholipase-C, protein kinase-A and -C in osteosarcoma cells. Endocrinology 130 (1992) 29-36
45. Seyle H. On the stimulation of new bone formation with parathyroid extract and irradiated ergosterol. Endocrinology 16 (1932) 547-548
46. Zarge J.I., Husak V., Huang P., and Greisler H.P. Fibrin glue containing fibroblast growth factor type 1 and heparin decreases platelet deposition. Am J Surg 174 (1997) 188-192
47. Schmoekel H., Schense J.C., Weber F.E., Gratz K.W., Gnagi D., Muller R., et al. Bone healing in the rat and dog with nonglycosylated BMP-2 demonstrating low solubility in fibrin matrices. J Orthop Res 22 (2004) 376-381
48. Meinhart J.G., Schense J.C., Schima H., Gorlitzer M., Hubbell J.A., Deutsch M., et al. Enhanced endothelial cell retention on shear-stressed synthetic vascular grafts precoated with RGD-cross-linked fibrin. Tissue Eng 11 (2005) 887-895
49. Yamada Y., Boo J.S., Ozawa R., Nagasaka T., Okazaki Y., Hata K., et al. Bone regeneration following injection of mesenchymal stem cells and fibrin glue with a biodegradable scaffold. J Craniomaxillofac Surg 31 (2003) 27-33
50. Chalidis B., Tzioupis C., Tsiridis E., and Giannoudis P.V. Enhancement of fracture healing with parathyroid hormone: preclinical studies and potential clinical applications. Expert Opin Investig Drugs 16 (2007) 441-449